Skip header and navigation

1 record – page 1 of 1.

Adalimumab (Humira®) therapy

http://libcat.nshealth.ca/permalink/chpams35127
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1207
Available Online
View Pamphlet
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Other Subjects
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1207